Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propolis as a New Strategy in Modulating Inflammation in Patients With Chronic Kidney Disease.

NCT04411758 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.

NCT NCT04411758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propolis as a New Strategy in Modulating Inflammation in Patients With Chronic Kidney Disease.
Lead sponsor
Universidade Federal Fluminense
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2021
Completion date
December 31, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, inflammation